Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae

被引:22
|
作者
Hayakawa, Kayoko [1 ]
Nakano, Ryuichi [2 ]
Hase, Ryota [3 ]
Shimatani, Michitsugu [4 ]
Kato, Hideaki [5 ]
Hasumi, Jumpei [6 ]
Doi, Asako [7 ]
Sekiya, Noritaka [8 ]
Nei, Takahito [9 ]
Okinaka, Keiji [10 ]
Kasahara, Kei [11 ]
Kurai, Hanako [12 ]
Nagashima, Maki [1 ]
Miyoshi-Akiyama, Tohru [13 ]
Kakuta, Risako [2 ]
Yano, Hisakazu [2 ]
Ohmagari, Norio [1 ]
机构
[1] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan
[2] Nara Med Univ, Dept Microbiol & Infect Dis, Nara, Japan
[3] Japanese Red Cross Narita Hosp, Dept Infect Dis, Chiba, Japan
[4] Hamamatsu Med Ctr, Dept Infect Dis & Infect Control, Shizuoka, Japan
[5] Yokohama City Univ Med, Infect Prevent & Control Dept, Yokohama, Kanagawa, Japan
[6] Saku Med Ctr, Dept Pediat, Nagano, Japan
[7] Kobe City Med Ctr Gen Hosp, Div Infect Dis, Kobe, Hyogo, Japan
[8] Komagome Hosp, Dept Infect Prevent & Control, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[9] Nippon Med Coll Hosp, Dept Infect Prevent & Control, Tokyo, Japan
[10] Natl Canc Ctr Hosp East, Div Gen Internal Med, Chiba, Japan
[11] Nara Med Univ, Ctr Infect Dis, Nara, Japan
[12] Shizuoka Canc Ctr, Div Infect Dis, Shizuoka, Japan
[13] Natl Ctr Global Hlth & Med, Res Inst, Pathogen Microbe Lab, Tokyo, Japan
关键词
ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; INACTIVATION METHOD; MULTIPLEX PCR; PREVALENCE; OUTCOMES; HEALTH; JAPAN;
D O I
10.1093/jac/dkz501
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are classified as carbapenemase-producing Enterobacteriaceae (CPE) and non-CPE; the majority of CPE in Japan produce IMP carbapenemase. Objectives: We evaluated the clinico-epidemiological and microbiological information and effects of IMP-type carbapenemase production in CRE. Methods: Patients with isolations of CRE (MICs of meropenem >= 2mg/L, imipenem >= 2mg/L or cefmetazole >= 64mg/L) from August 2016 to March 2018 were included. Microbiological analyses and WGS were conducted and clinical parameters were compared between groups. Independent predictors for the isolation of CPE from patients were identified by logistic regression. For comparing clinical outcomes, a stabilized inverse probability weighting method was used to conduct propensity score-adjusted analysis. Results: Ninety isolates (27 CPE and 63 non-CPE) were collected from 88 patients (25 CPE and 63 non-CPE). All CPE tested positive for IMP carbapenemase. Antibiotic resistance (and the presence of resistance genes) was more frequent in the CPE group than in the non-CPE group. Independent predictors for CPE isolation were residence in a nursing home or long-term care facility, longer prior length of hospital stay (LOS), use of a urinary catheter and/or nasogastric tube, dependent functional status and exposure to carbapenem. Although in-hospital and 30 day mortality rates were similar between the two groups, LOS after CRE isolation was longer in the CPE group. Conclusions: IMP-CPE were associated with prolonged hospital stays and had different clinical and microbiological characteristics compared with non-CPE. Tailored approaches are necessary for the investigational and public health reporting, and clinical and infection prevention perspectives for IMP-CPE and non-CPE.
引用
收藏
页码:697 / 708
页数:12
相关论文
共 50 条
  • [31] Epidemiology, treatment and mortality in infection by carbapenemase-producing Enterobacteriaceae: retrospective study
    Antequera M, Alba
    Saez B, Carmen
    Ciudad S, Marianela
    Garcia B, Maria Jose
    Moyano V, Berta
    Rodriguez C, Pablo
    Roy V, Emilia
    Aguilera G, Maria
    Alonso N, Ester
    Cardenas I, Maria Jose
    Castro G, Sara
    Domingo G, Diego
    Barrios B, Ana
    REVISTA CHILENA DE INFECTOLOGIA, 2020, 37 (03): : 295 - 303
  • [32] Epidemiology of Carbapenemase-Producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean Countries
    Djahmi, Nassima
    Dunyach-Remy, Catherine
    Pantel, Alix
    Dekhil, Mazouz
    Sotto, Albert
    Lavigne, Jean-Philippe
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [33] Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia
    D'Onofrio, Valentino
    Conzemius, Rick
    Varda-Brkic, Dijana
    Bogdan, Maja
    Grisold, Andrea
    Gyssens, Inge C.
    Bedenic, Branka
    Barisic, Ivan
    INFECTION GENETICS AND EVOLUTION, 2020, 81
  • [34] Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children
    Ara-Montojo, M. F.
    Escosa-Garcia, L.
    Alguacil-Guillen, M.
    Seara, N.
    Zozaya, C.
    Plaza, D.
    Schuffelmann-Gutierrez, C.
    de la Vega, A.
    Fernandez-Camblor, C.
    Ramos-Boluda, E.
    Romero-Gomez, M. P.
    Ruiz-Carrascoso, G.
    Losantos-Garcia, I
    Mellado-Pena, M. J.
    Gomez-Gil, R.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (01) : 220 - 225
  • [35] Control of Carbapenemase-producing Enterobacteriaceae: Beyond the Hospital
    Cheng, Vincent C. C.
    Wong, Shuk-Ching
    Wong, Sally C. Y.
    Ho, Pak-Leung
    Yuen, Kwok-Yung
    ECLINICALMEDICINE, 2018, 6 : 3 - 4
  • [36] Dissemination of carbapenemase-producing Enterobacteriaceae in France, 2012
    Dortet, Laurent
    Cuzon, Gaelle
    Nordmann, Patrice
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (03) : 623 - 627
  • [37] Strategy for Rapid Detection of Carbapenemase-Producing Enterobacteriaceae
    Dortet, Laurent
    Brechard, Ludivine
    Cuzon, Gaelle
    Poirel, Laurent
    Nordmann, Patrice
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2441 - 2445
  • [38] First detection of a carbapenemase-producing Enterobacteriaceae in Iceland
    Helgason, Kristjan O.
    Jelle, Asdis E.
    Edvardsson, Vidar
    Findlay, Jacqueline
    Hopkins, Katie L.
    Woodford, Neil
    Samuelsen, Orjan
    Hardarson, Hordur S.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2016, 6 : 73 - 74
  • [39] Over-treatment of carbapenemase-producing Enterobacteriaceae
    Rihani, Deba S.
    Wallace, Mark R.
    Sieger, Barry E.
    Waite, Robert A.
    Fox, Marlena
    Brown, Scott A.
    Deryke, C. Andrew
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (05) : 325 - 329
  • [40] Managing Carbapenemase-producing Enterobacteriaceae In A Transplant Setting
    Hill, L.
    Dignan, F.
    Blagburn, N.
    Saif, M.
    Tholouli, E.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S560 - S560